81. Parkinson's Information Web Site The Parkinson s disease Information web site offers resources and informationfor individuals living with Parkinson s disease. Included http://www.parkinsonsinfo.com/

Neural network image provided by William C. Brown Publishers and Engineering Animation, Inc. This site best viewed with or above or with MS Internet Explorer 4.0 or above. Eldepryl Capsules, 5mg (selegiline hydrochloride) Product Labeling Somerset Pharmaceuticals, Inc. Please read our Mylan Laboratories Inc. Please direct comments, suggestions, and technical questions about the site to webmaster@somersetpharm.com Website created and maintained by Brady Interactive , a division of John Brady Design Consultants, Inc.

82. Parkinson's Disease - Neurologychannel Parkinson's disease is characterized by tremors or shaking of the limbs in an uncontrolled fashion. ADHD. ALS. Alzheimer's disease. Autism. Back Pain CharcotMarie-Tooth. disease. Chronic Pain. Dementia. Encephalitis Headache. Huntington's disease. Hydrocephalus. Lou Gehrig's disease. Lyme http://www.neurologychannel.com/parkinsonsdisease

Home Search SiteMap Ask the Dr. ... Medical Store advertisement PARKINSON'S DISEASE Overview Causes Symptoms Diagnosis ... Videos CONDITIONS ADHD ALS Alzheimer's Disease Autism ... Carpal Tunnel Syndrome Cephalic Disorders Cerebral Palsy Charcot-Marie-Tooth Disease Chronic Pain Dementia Encephalitis Epilepsy ... Guillain-Barre Syndrome Headache Huntington's Disease Hydrocephalus Lou Gehrig's Disease ... Traumatic Brain Injury Vertigo TREATMENT OPTIONS Botulinum Toxin Therapy Epidural Injection Trigger Point Injection Vagus Nerve Stimulation RESOURCES neurologychannelMD Clinical Trials Links MDLocator ... What Is a Neurologist? Videos ABOUT US Healthcommunities.com Pressroom Testimonials print this ... email this Overview Parkinson’s disease is a chronic, progressive neurodegenerative movement disorder. Tremors, rigidity, slow movement (bradykinesia), poor balance, and difficulty walking (called parkinsonian gait) are characteristic primary symptoms of Parkinson’s disease. Idiopathic Parkinson's disease is the most common form of parkinsonism, a group of movement disorders that have similar features and symptoms. Parkinson’s disease is called idiopathic Parkinson’s because the cause is unknown. In the other forms of parkinsonism, a cause is known or suspected. Parkinson’s results from the degeneration of dopamine-producing nerve cells in the brain, specifically in the substantia nigra and the locus coeruleus. Dopamine is a neurotransmitter that stimulates motor neurons, those nerve cells that control the muscles. When dopamine production is depleted, the motor system nerves are unable to control movement and coordination. Parkinson's disease patients have lost 80% or more of their dopamine-producing cells by the time symptoms appear.

83. PDF - Parkinson S Disease Foundation, Inc. The following are the most common primary symptoms of Parkinson s disease. Thereare many secondary symptoms of Parkinson s disease. http://www.pdf.org/AboutPD/symptoms.cfm

84. Parkinson's Disease Clinical Studies Parkinson s disease Clinical Studies. Patients needed Health. Researchstudy for the treatment of early Parkinson s disease. Center http://www.parkinson.org/clnindex.htm

Parkinson's Disease Clinical Studies Patients Needed for NIH funded study titled "Treatment of Depression Associated with Parkinson's Disease using S-Adenosyl-Methionine" Depression is a common problem among people with Parkinson's Disease. Depression affects 30-60% of patients according to some estimates, but its cause is currently unknown. Patients needed for research study on exercise for Parkinson's disease Patients needed for research study on exercise for Parkinson's disease Colorado Neurological Institute and the University of Colorado Health Sciences Center in Denver, Colorado is conducting a research study to determine which of three exercise programs is best for improving day to day activities and fitness for people with Parkinson's disease. NIH funded study titled Study of Antidepressants in Parkinson's Disease Depression is the most common non-motor symptom of Parkinson's disease Depression is the most common non-motor symptom of Parkinson's disease (PD), and approximately 50% of people with PD will experience symptoms of depression during the course of their illness. Depressive symptoms may include "psychological" symptoms such as feelings of sadness or hopelessness as well as "physical" symptoms such as fatigue and changes in sleeping patterns.. Clinical trials for patients with Dementia, Essential Tremors, swallowing dysfunction and for patients with PD symptoms limited to one side of the body

85. Aging Research; Molecular Concepts Of Aging, Related Diseases And Cloning. Research on aging, molecular concepts of aging, cloning and agerelated diseases such as Alzheimers, Werner syndrome, and parkinsons. http://www.innovitaresearch.org/

Home Aging news General Cloning Diseases ... Contact us Innovita Research Foundation web site is intended for readers who want to find out qualified information about aging in general and in molecular approach. The point is to emphasize main problems of aging, to reduce aging factors, and to answer the perpetual question what is aging and how it is influenced by our genetic composition and lifestyle. Aging is a natural stage of human development. In this period adaptivity of organisms' reduces (onset of age related diseases, general run-out of organism). There are possible opportunities to change it; modify the course of aging in the position that the aging person could live sterling life, and as long as possible could stay highly adaptive and valuable to the society. Our objective is to declare and systematize information about aging elements and linked processes. In this web site large (more than 200 pages, more than 1000 papers are overviewed) aging literature survey is presented. Aging News General - here you can find reviews of the articles and information about aging in general (aging process; factors of aging; ways to slower this process etc.) Aging News Cloning - displays information and article reviews about use of cloning in aging.

86. About Parkinson's Disease Understanding Parkinson s disease. How Our Brain Controls Our Movement What Happensin Parkinson s disease. Parkinson s disease and the Role of Therapy. http://www.parkinsonsinfo.com/about_parkinsons/

Understanding Parkinson's Disease How Our Brain Controls Our Movement What Happens in Parkinson's Disease Parkinson's Disease and the Role of Therapy Medicine Combination Pays Off Generic Drugs: Understanding the Issues Real Cost of Generic Selegiline HCl Tablets Drug Therapy in Managing the Effects of Parkinson's Disease ... Other Ways to Manage the Effects of Parkinson's Disease Tips for Daily Living Steady on Your Feet In the Livingroom In the Bathroom In the Kitchen ... Traveling Parkinson's Disease Research New Medicines Aim to Improve Symptom Control Fetal Cell Implants and Pallidotomy New Study Shows Genetic Link to PD Looking Over the Shoulders of PD Research Scientists Positive Living with Parkinson's Disease Home Improvements: Where to Go for the Right PD Tools Financial Fitness: Coping With the Expense and Disability of PD Talking to Your Pharmacist You Are What You Eat ... A Holiday Wish List Sponsored by Somerset Pharmaceuticals, Inc. Somerset Pharmaceuticals, Inc. Please read our Mylan Laboratories Inc.

87. NINDS Parkinson's Disease Information Page Parkinson s disease information sheet compiled by the National Institute ofNeurological Disorders and Stroke (NINDS). More about Parkinson s disease, http://www.ninds.nih.gov/health_and_medical/disorders/parkinsons_disease.htm

National Institute of Neurological Disorders and Stroke Accessible version Science for the Brain The nation's leading supporter of biomedical research on disorders of the brain and nervous system Browse all disorders Browse all health organizations More about Parkinson's Disease Studies with patients Research literature Press releases Search NINDS... (help) Contact us My privacy NINDS is part of the National Institutes of Health NINDS Parkinson's Disease Information Page Reviewed 08-17-2001 Get Web page suited for printing Email this to a friend or colleague Table of Contents (click to jump to sections) What is Parkinson's Disease? Is there any treatment? What is the prognosis? What research is being done? ... Additional resources from MEDLINEplus What is Parkinson's Disease? Is there any treatment? A variety of medications provide dramatic relief from the symptoms, but no drug can stop the progression of the disease. In some cases, surgery is an appropriate treatment. Some doctors recommend physical therapy or muscle-strengthening exercises. What is the prognosis?

88. Parkinson's Disease - Hope Through Research An informational booklet on Parkinson s disease compiled by the National Instituteof Neurological Disorders and Stroke (NINDS). What is Parkinson s disease? http://www.ninds.nih.gov/health_and_medical/pubs/parkinson_disease_htr.htm

National Institute of Neurological Disorders and Stroke Accessible version Science for the Brain The nation's leading supporter of biomedical research on disorders of the brain and nervous system Browse all disorders Browse all health organizations More about a disorder Studies with patients Research literature Press releases Search NINDS... (help) Contact us My privacy NINDS is part of the National Institutes of Health Parkinson's Disease — Hope Through Research Get Web page suited for printing Email this to a friend or colleague Request free mailed brochure Table of Contents Introduction What is Parkinson's Disease? What Causes the Disease? Who Gets Parkinson's Disease? ... Information Update Introduction Parkinson's disease may be one of the most baffling and complex of the neurological disorders. Its cause remains a mystery but research in this area is active, with new and intriguing findings constantly being reported. Parkinson's disease was first described in 1817 by James Parkinson, a British physician who published a paper on what he called "the shaking palsy." In this paper, he set forth the major symptoms of the disease that would later bear his name. For the next century and a half, scientists pursued the causes and treatment of the disease. They defined its range of symptoms, distribution among the population, and prospects for cure. In the early 1960s, researchers identified a fundamental brain defect that is a hallmark of the disease: the loss of brain cells that produce a chemical —

89. World Parkinson Disease Association (WPDA) Association of lay Parkinson s disease associations. The most comprehensivesource of Parkinson s disease information and news. http://www.wpda.org/

Updated: APDA fellowships and research grants for academic year 2004-2005 WPDA is sponsoring a Symposium scheduled to be held in Amsterdam April 16 and 17, 2004 . Scientific program to be presented April 16 and the morning of April 17. Roundtable business meeting for member associations only afternoon April 17. For more informations contact Paul Maestrone e-mail: PaulM@apdaparkinson.org phone: fax: New publications added for APDA, Brazil and Canada on March 2002 See the new indexed list of articles now available for patients and caregivers. Helpful information and suggestions selected for varied situations and problems encountered on a daily basis. New articles added December 2002: 3 more in Basic Management Drinking liquids Alternative therapy Music in PD The "Other Treatments" section's articles have been transferred into the new section " Other treatments (non pharmacological) The former section remains as " Other treatments-pharmacological Second WPDA Conference (1999): summary Pergolide and restrictive valvular heart disease (RVHD).

90. Parkinson's Disease: New Treatments Slow Onslaught Of Symptoms New therapies can help ease the debilitating symptoms of Parkinson s disease, buttreatments currently on the market can neither replace the faulty nerve cells http://www.fda.gov/fdac/features/1998/498_pd.html

Table of Contents Parkinson's Disease: New Treatments Slow Onslaught of Symptoms by John Henkel Joe Dulaney calls himself the Backward Man. Although the tag is lighthearted, the awkward and dangerous dilemma he often faces as his lower limbs simply lock in mid-stride is not. At these moments, his body halts abruptly like a movie freeze-frame, and the only way he can walk is to step backward. "I've gotten to where I can move pretty fast in reverse," says Illinois resident Dulaney, 65, whose finessed footwork helps him cope with one of many symptoms of Parkinson's disease. Nationwide, as many as 1.5 million people suffer from Parkinson's, according to the Parkinson's Disease Foundation. A chronic and progressive disorder, Parkinson's strikes slightly more men than women and more whites than blacks in the United States. Though the disease is found most often in patients over 50, as many as 10 percent of patientsafflicted with the so-called "young-onset" Parkinson'sare under 40. About 50,000 Americans are diagnosed with Parkinson's yearly, according to the National Institute of Neurological Disorders and Stroke, which estimates that the total cost of health care for Parkinson's patients will exceed $5.6 billion this year. The Food and Drug Administration has approved nearly a dozen drugs for treating Parkinson's, three of which have been put on the market just in the past year. Also approved in 1997 was a device that is surgically implanted in the brain to lessen the violent shaking experienced by some Parkinson's patients. The 1996 discovery of a gene believed responsible for a form of Parkinson's may result in future innovative treatments. Despite the range of therapies available to ease the disease's debilitating symptoms, however, treatments now on the market can neither replace the faulty nerve cells that cause the disease nor stop Parkinson's from progressing.

91. Michael J. Fox Foundation The Michael J. Fox Foundation for Parkinson s Research is dedicated to ensuring thedevelopment of a cure for Parkinson s disease within this decade through an http://www.michaeljfox.org/

Research News and Events About the Foundation How to Help ... About Michael The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease within this decade through an aggressively funded research agenda. Over $40 million in research funded since November 2000. WHAT'S NEW LEAPS Collaboration To Create First Genetic Map of Parkinson's Disease The initial award under the LEAPS program will aim to create the first whole genome study, or genetic map, of Parkinson's disease within one year. Community Fast Track, 2004 Initiative The Michael J. Fox Foundation for Parkinson's Research (MJFF) announces the launch of Community Fast Track 2004 , a grant program supported by MJFF and other regional and national Parkinson’s organizations. Parkinson’s Disease Cell Loss Starts Years Before Diagnosis Medical News Today reports that new research indicates the loss of brain cells that leads to Parkinson’s disease starts an estimated 13 years before the diagnosis. OUR VISION Message From Michael Click here for more information.

92. Parkinson's Disease Teaching Presentation. Information On History, Epidemiology, Parkinson s disease Presentation for patients, family and rehabilitationteam members. Information on history, epidemiology, clinical http://dna2z.com/projects/PD/

Parkinson's Disease A teaching presentation on Parkinson's Disease For families patients and rehabilitation team members : The information presented here is for informational purposes only . I take no responsibility for any consequences of anyone interpreting or misinterpreting the information presented here. Always consult your physician if you have any questions. Search: All Products Books Magazines Popular Music Classical Music Video DVD Baby Electronics Software Outdoor Living Wireless Phones Keywords: Posted: April 18th 1996

93. European Parkinson's Disease Association Comprehensive site includes information on the EPDA's aims and objectives; conferences; publications; http://www.shef.ac.uk/misc/groups/epda/home.html

94. Parkinson Society Canada which raises money through corporate sponsorships, public donations, and plannedgifts to support the search for the cure and cure for Parkinson s disease. http://www.parkinson.ca/

95. Parkinson's Disease | Parkinson Society Canada Parkinson s disease is a slowly progressive neurodegenerative illness characterizedby tremor, stiffness, (rigidity), slowness of movement (bradykinesia) and http://www.parkinson.ca/pd/parkinson.html

Parkinson's Disease Description of Parkinson's Parkinson's Disease is a slowly progressive neurodegenerative illness characterized by: tremor, stiffness, (rigidity), slowness of movement (bradykinesia) and difficulty with balance (postural instability). The symptoms appear when there is not enough dopamine in the brain. Video: Living with Parkinson's Disease Meet Pat Fleming , a Parkinson Society Canada volunteer, who has lived with Parkinson's Disease for the last 15 years. This video requires the latest RealPlayer plug-in for viewing. Need More Information? daniel.thibault@parkinson.ca Site Map Home FAQs ... Volunteering 4211 Yonge Street, Suite 316 Toronto, Ontario M2P 2A9 Tel : 416-227-9700 Fax: 416-227-9600 Toll Free: 1-800-565-3000 Email: General.info@parkinson.ca please click here svp cliquez ici

96. WE MOVE - Parkinson's Disease If you or someone you are close to has Parkinson s disease (PD), pleaseread this section. You Parkinson s disease. » Parkinson s http://www.wemove.org/par/

WE MOVE 204 West 84th Street New York, NY 10024 Tel: 800-437-MOV2 Fax: 212-875-8389 E-mail: wemove@wemove.org Parkinson's Disease Parkinson's Disease Information for Patients and Caregivers (see table of contents below) Parkinson's Disease Information for Patients and Caregivers Table of Contents Overview of Parkinson's Disease Frequently Asked Questions Parkinson's Disease Treatments Nonpharmacologic Treatments ... New Hope for Parkinson's WE MOVE makes every effort to present medical information that is up-to-date and accurate. The material provided has undergone rigorous medical review. Information regarding the authors, editors, publisher, and medical reviewers of this material of the WE MOVE Web site is listed below. Medical science is constantly changing. Therefore, the authors, editors, and publisher do not warrant that the information in this text is complete, nor are they responsible for omissions or errors in the text or for the results of the use of this information. This information does not replace consultation with a physician. All medical procedures, drug doses, indications, and contraindications should be discussed with your personal physician. Medical Editor: Richard Robinson Medical Review: Mark Stacy, MD; Kapil D. Sethi, MD

97. MedlinePlus: Parkinson's Disease General/Overviews; Parkinson s disease (Mayo Foundation for Medical Educationand Research); View slideshow on Pallidotomy Parkinson s disease. http://www.nlm.nih.gov/medlineplus/parkinsonsdisease.html

@import url(http://www.nlm.nih.gov/medlineplus/images/advanced.css); Skip navigation Other health topics: A B C D ... List of All Topics Parkinson's Disease Contents of this page: News From the NIH General/Overviews Coping ... Teenagers Search MEDLINE/PubMed for recent research articles on Parkinson's Disease: General Diagnosis Causes Prognosis ... Therapy You may also be interested in these MedlinePlus related pages: Movement Disorders Brain and Nervous System Seniors' Health Latest News Safer Gene Therapy Delivery Found (06/08/2004, United Press International) Clozapine Curbs Psychosis in Parkinson's Patients (05/13/2004, Reuters Health) FDA Approves Apokyn for the Acute Treatment of Episodes of Immobility in Parkinson’s Patients (04/21/2004, Food and Drug Administration) From the National Institutes of Health Parkinson's Disease Backgrounder (National Institute of Neurological Disorders and Stroke) Parkinson's Disease: Hope Through Research (National Institute of Neurological Disorders and Stroke) Also available in: Spanish General/Overviews Parkinson's Disease (Mayo Foundation for Medical Education and Research) Parkinson's Disease (Patient Education Institute) - requires Flash plug-in Also available in: Spanish Parkinson's Disease (We Move) Alternative Therapy Complementary Therapies and Parkinson's Disease (National Parkinson Foundation, Inc.)

98. EPDA - EUROPEAN PARKINSON'S DISEASE ASSOCIATION Professional organization focused on research and treatment of Parkinson disease. http://www.epda.eu.com/

99. Parkinson's Disease, Michael Fox, MS And The Aspartame Story Parkinson s disease, Michael Fox, MS And The Aspartame Story From Betty MartiniBettym19@mindspring.com Mission Possible International www.dorway.com 43-2 http://www.rense.com/general21/parkinsonFox.htm

Rense.com Parkinson's Disease, Michael Fox, MS And The Aspartame Story From Betty Martini Bettym19@mindspring.com Mission Possible International www.dorway.com Dear Oprah, What is the common denominator in these folks, and three others who worked with Michael Fox and also developed Parkinson's Disease? You're looking for a neurotoxin/excitotoxin. An excitotoxin is a product that literally stimulates the neurons of the brain to death causing brain damage of varying degrees. It was the famed Dr. John Olney who founded the field of neuroscience called excitotoxicity. He did studies on aspartic acid, 40% of aspartame, and found it caused lesions in the brains of mice. It is an excitotoxin. Neurosurgeon Russell Blaylock, M.D., wrote the book on it, Excitotoxins: The Taste That Kills . He discusses Parkinson's Disease at length. Dr. Blaylock gives several points on the disease. He says "Parkinson's Disease is a disorder whose cause appears from substantial evidence, to be related to excitotoxicity. These toxins destroy the cells in the brain central to this disease. Excitotoxins cause these brain cells to generate enormous amounts of free radicals. This is true of MSG and aspartic acid (aspartame).There is substantial circumstantial evidence that dietary excitotoxins, including aspartame, can aggravate these destructive changes in the Parkinson's brain. The additional toxins - DKP, aspartate, methanol, formaldehyde and formic acid - add to this injury. Recent evidence demonstrates that the aspartame product, formaldehyde - accumulates within cells and damages protein and DNA. "

100. Parkinson's Victoria http://www.parkinsons-vic.org.au/

var monthList = new Array('January', 'February', 'March', 'April', 'May', 'June', 'July', 'August', 'September', 'October', 'November', 'December');

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 5     81-100 of 121    Back | 1  | 2  | 3  | 4  | 5  | 6  | 7  | Next 20